SYNDYMA Trademark

Trademark Overview

On Monday, May 10, 2010, a trademark application was filed for SYNDYMA with the United States Patent and Trademark Office. The USPTO has given the SYNDYMA trademark a serial number of 85034099. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2013. This trademark is owned by GENENTECH, INC.. The SYNDYMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders
syndyma

General Information

Serial Number85034099
Word MarkSYNDYMA
Filing DateMonday, May 10, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 14, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Trademark Events

Event DateEvent Description
Monday, July 8, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 8, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, December 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, December 13, 2012EXTENSION 4 GRANTED
Friday, December 7, 2012EXTENSION 4 FILED
Tuesday, December 11, 2012NOTICE OF REVIVAL - MAILED
Tuesday, December 11, 2012EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, December 11, 2012PETITION TO REVIVE-GRANTED
Tuesday, December 11, 2012TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 5, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, June 4, 2012EXTENSION 3 GRANTED
Friday, May 25, 2012EXTENSION 3 FILED
Friday, May 25, 2012TEAS EXTENSION RECEIVED
Wednesday, December 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, December 20, 2011EXTENSION 2 GRANTED
Tuesday, December 6, 2011EXTENSION 2 FILED
Tuesday, December 20, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 6, 2011TEAS EXTENSION RECEIVED
Tuesday, June 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, June 3, 2011EXTENSION 1 GRANTED
Friday, June 3, 2011EXTENSION 1 FILED
Friday, June 3, 2011TEAS EXTENSION RECEIVED
Tuesday, December 7, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 12, 2010PUBLISHED FOR OPPOSITION
Wednesday, September 22, 2010NOTICE OF PUBLICATION
Friday, September 3, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 3, 2010ASSIGNED TO LIE
Sunday, August 22, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, August 22, 2010ASSIGNED TO EXAMINER
Friday, May 14, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 13, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

syndyma diseases disorders angiogenesis ocular inflammatory immune oncological cardiovascular preparations pharmaceutical